Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Japan · Delayed Price · Currency is JPY

299.00

+1.00 (0.34%)

Apr 21, 2026, 3:30 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Others Business	5.00M	5.00M	5.00M	7.00M	6.00M
Others Business Growth	0%	0%	-28.57%	16.67%	-
Infection Control Business	619.00M	508.00M	929.00M	1.41B	6.94B
Infection Control Business Growth	21.85%	-45.32%	-34.02%	-79.72%	-
Pharmaceutical Business	5.77B	5.78B	5.19B	3.62B	4.35B
Pharmaceutical Business Growth	-0.12%	11.44%	43.07%	-16.69%	-
Total	6.40B	6.29B	6.12B	5.04B	11.30B
Total Growth	1.65%	2.81%	21.43%	-55.40%	-

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Japan	4.08B	4.03B	4.19B	3.78B	9.61B
Japan Growth	1.17%	-3.66%	10.89%	-60.73%	-
China / Hong Kong	1.87B	1.94B	1.62B	1.00B	1.14B
China / Hong Kong Growth	-3.15%	19.67%	61.70%	-12.51%	-
Taiwan	337.00M	260.00M	234.00M	192.00M	406.00M
Taiwan Growth	29.62%	11.11%	21.88%	-52.71%	-
Others	105.00M	62.00M	81.00M	71.00M	136.00M
Others Growth	69.35%	-23.46%	14.08%	-47.79%	-
Total	6.40B	6.29B	6.12B	5.04B	11.30B
Total Growth	1.69%	2.81%	21.44%	-55.40%	-

Source: S&P Global Market Intelligence.